HopeStage
Back to all studies
Not Yet RecruitingNCT07668635

Cannabis Effects on Opioid Self-Administration

Medication studyAges 18–55United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
LexingtonSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: November 30, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
30
Sponsor
Shanna Babalonis, PhD
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT07668635
Official title
Show the full official title

Impact of Cannabis on Opioid Self-Administration

Recruitment & locations

Not yet recruiting

Lexington

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Shanna Babalonis, PhD.

Does this study involve medication?

Yes. The study involves medication, including Cannabis, Placebo Cannabis, Intranasal Opioid Agonist and Oral Opioid Agonist.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies